ZA972831B - Process for the preparation of enantiomerically pure cyclo-alkano-indol-and azaindol -and pyrimido [1,2A] indolcarbocyclic acids and their activated derivatives. - Google Patents

Process for the preparation of enantiomerically pure cyclo-alkano-indol-and azaindol -and pyrimido [1,2A] indolcarbocyclic acids and their activated derivatives.

Info

Publication number
ZA972831B
ZA972831B ZA9702831A ZA972831A ZA972831B ZA 972831 B ZA972831 B ZA 972831B ZA 9702831 A ZA9702831 A ZA 9702831A ZA 972831 A ZA972831 A ZA 972831A ZA 972831 B ZA972831 B ZA 972831B
Authority
ZA
South Africa
Prior art keywords
indolcarbocyclic
azaindol
alkano
pyrimido
indol
Prior art date
Application number
ZA9702831A
Other languages
English (en)
Inventor
Jan-Bernd Lenfers
Peter Fey
Paul Naab
Kai Van Laak
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA972831B publication Critical patent/ZA972831B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C07C69/616—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62—Halogen-containing esters
    • C07C69/65—Halogen-containing esters of unsaturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA9702831A 1996-04-04 1997-04-03 Process for the preparation of enantiomerically pure cyclo-alkano-indol-and azaindol -and pyrimido [1,2A] indolcarbocyclic acids and their activated derivatives. ZA972831B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19613549A DE19613549A1 (de) 1996-04-04 1996-04-04 Verfahren zur Herstellung von enantiomerenreinen Cycloalkano-indol- und azaindol-carbonsäuren und deren aktivierte Derivate

Publications (1)

Publication Number Publication Date
ZA972831B true ZA972831B (en) 1997-10-31

Family

ID=7790501

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9702831A ZA972831B (en) 1996-04-04 1997-04-03 Process for the preparation of enantiomerically pure cyclo-alkano-indol-and azaindol -and pyrimido [1,2A] indolcarbocyclic acids and their activated derivatives.

Country Status (27)

Country Link
US (1) US5952498A (fr)
EP (1) EP0799829B1 (fr)
JP (2) JP4235268B2 (fr)
KR (1) KR970069988A (fr)
CN (2) CN1067394C (fr)
AR (2) AR006544A1 (fr)
AT (1) ATE246193T1 (fr)
AU (1) AU722592B2 (fr)
BR (1) BR9701672A (fr)
CA (1) CA2201435C (fr)
CZ (1) CZ102197A3 (fr)
DE (2) DE19613549A1 (fr)
DZ (1) DZ2202A1 (fr)
EE (1) EE9700079A (fr)
ES (1) ES2202506T3 (fr)
HR (1) HRP970178A2 (fr)
HU (1) HU218494B (fr)
ID (1) ID16794A (fr)
IL (1) IL120591A (fr)
MA (1) MA24130A1 (fr)
NO (2) NO308301B1 (fr)
NZ (1) NZ314498A (fr)
PL (1) PL319269A1 (fr)
SG (1) SG60050A1 (fr)
SK (1) SK42897A3 (fr)
TN (1) TNSN97060A1 (fr)
ZA (1) ZA972831B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4435477A1 (de) 1994-10-04 1996-04-11 Bayer Ag Cycloalkano-indol- und -azaindol-derivate
AU2001244635A1 (en) * 2000-03-30 2001-10-15 Yamanouchi Pharmaceutical Co..Ltd. Hydrazide derivatives
WO2005051382A1 (fr) * 2003-11-28 2005-06-09 Astellas Pharma Inc. Agent renforçant l'effet hypolipidemiant
WO2005087234A1 (fr) * 2004-03-05 2005-09-22 The Trustees Of The University Of Pennsylvania Traitement a faibles effets secondaires contre des affections liees a l'hyperlipidemie et l'hypercholesterolemie
AU2005230397B2 (en) * 2004-04-09 2010-04-08 Elanco Animal Health Ireland Limited Intermittent dosing regimen for the treatment of overweight with MTP-inhibitors
EP1951220A2 (fr) * 2005-10-18 2008-08-06 Aegerion Pharmaceuticals Compositions destinees a l'abbaissement du cholesterol serique et/ou des triglycerides
US20080051427A1 (en) * 2006-05-18 2008-02-28 Fritz Schuckler Pharmaceutical Compositions and Methods of Using Same
WO2008079398A1 (fr) * 2006-12-21 2008-07-03 Aegerion Pharmaceuticals, Inc. Procédés de traitement de l'obésité à l'aide d'une combinaison comprenant un inhibiteur de mtp et un inhibiteur de l'absorption du cholestérol
WO2008124384A2 (fr) * 2007-04-03 2008-10-16 Aegerion Pharmaceuticals, Inc. Méthodes de traitement de l'hépatite c
JP6721499B2 (ja) 2013-03-14 2020-07-15 オステオーク インコーポレイティド 骨の成長を促進するためのアルキルアミンハルミン誘導体
MX2021001752A (es) 2018-08-14 2021-06-23 Osteoqc Inc Compuestos de pirrolo-dipiridina.
AU2019320773A1 (en) 2018-08-14 2021-03-04 Osteoqc Inc. Fluoro β-carboline compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
DE4200954A1 (de) * 1991-04-26 1992-10-29 Bayer Ag Heterocyclisch substituierte phenylessigsaeurederivate
DE4208051A1 (de) * 1992-03-13 1993-09-16 Bayer Ag Substituierte phenylessigsaeureamide
DE4302956A1 (de) * 1993-02-03 1994-08-04 Bayer Ag Substituierte Imidazo(4,5-b)pyridine und Benzimidazole
DE4435477A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Cycloalkano-indol- und -azaindol-derivate

Also Published As

Publication number Publication date
SK42897A3 (en) 1997-10-08
JP4235268B2 (ja) 2009-03-11
CN1184109A (zh) 1998-06-10
BR9701672A (pt) 1998-11-03
NO971513L (no) 1997-10-06
EP0799829B1 (fr) 2003-07-30
HUP9700698A1 (hu) 1998-01-28
KR970069988A (ko) 1997-11-07
NZ314498A (en) 1999-09-29
DE19613549A1 (de) 1997-10-09
CN1330065A (zh) 2002-01-09
EE9700079A (et) 1997-10-15
NO20003784L (no) 1997-10-06
NO308301B1 (no) 2000-08-28
NO20003784D0 (no) 2000-07-24
HU9700698D0 (en) 1997-05-28
MX9702446A (es) 1997-10-31
MA24130A1 (fr) 1997-10-01
JPH1045759A (ja) 1998-02-17
AU1660297A (en) 1997-10-09
NO971513D0 (no) 1997-04-03
DZ2202A1 (fr) 2002-12-03
CZ102197A3 (en) 1997-10-15
HRP970178A2 (en) 1998-04-30
HU218494B (hu) 2000-09-28
EP0799829A1 (fr) 1997-10-08
ID16794A (id) 1997-11-13
CA2201435C (fr) 2006-12-12
DE59710487D1 (de) 2003-09-04
AR012048A2 (es) 2000-09-27
IL120591A (en) 2000-11-21
PL319269A1 (en) 1997-10-13
US5952498A (en) 1999-09-14
AU722592B2 (en) 2000-08-10
SG60050A1 (en) 1999-02-22
JP2008169218A (ja) 2008-07-24
IL120591A0 (en) 1997-08-14
TNSN97060A1 (fr) 2005-03-15
ES2202506T3 (es) 2004-04-01
ATE246193T1 (de) 2003-08-15
CN1067394C (zh) 2001-06-20
AR006544A1 (es) 1999-09-08
CA2201435A1 (fr) 1997-10-04

Similar Documents

Publication Publication Date Title
ZA9710322B (en) Process for the preparation of benzyl-ethers.
HUP9800555A3 (en) 3,3-diphenylallylamine derivatives and process for their preparation
EP0685504A3 (fr) Dérivés d'acide polyaspartique et procédé pour leur préparation.
ZA972831B (en) Process for the preparation of enantiomerically pure cyclo-alkano-indol-and azaindol -and pyrimido [1,2A] indolcarbocyclic acids and their activated derivatives.
HUP9903459A3 (en) Oxa- and tiabicyclo[3.1.0]hexane-carboxylic acids, process for their preparation and pharmaceutical compositions of the same
HUP9603527A2 (en) 3-amino-2-mercaptobenzoic acid derivatives and processes for their and the intermediers preparation and the intermediers
HU9700708D0 (en) Pyrimido[1,2-a]indole derivatives and process for producing them
HK1010885A1 (en) 10,13,15-trioxatricyclo [9.2.1.1.9.6]-pentadecanone-derivatives, process for their preparation and pharmaceutical containing them
AU4729396A (en) Process for the preparation of 1,2-benzisothiazolin-3-ones
ZA967537B (en) Novel carboxylic acid derivatives, their preparation and use.
AU2742397A (en) Processes for producing 1,6-hexanedials and derivatives
AU6778796A (en) Process for the preparation of 1,4-butenediol
AU2622397A (en) Fluoroalkylglycosiduronic acids and corresponding 6(3)-lactones, preparation and uses
IL119868A0 (en) Process for the preparation of 4,4'-oxybisphthalic dianhydride
ZA973796B (en) New efficient and highly enantioselective process for the preparation of enantiomerically pure cyclopentane-ß-amino acids.
EP0945433A4 (fr) Procede de preparation d'acides acyloxyalcanesulfoniques
HUP9700628A3 (en) 4-thia-1-aza-bicyclo[3.2.0]heptan-3-imino-2-izopropiliden-7-oxo-beta-lactame derivatives, process for producing them and use of them
ZA976828B (en) 6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepine-3-acetic acid derivatives, their preparation and their application in therapy.
IL120285A (en) Process for the preparation of 1,5-benzothiazepine derivatives, process for the preparation of the intermediate thereof and an intermediate thereof
ZA955514B (en) Process for the preparation of 5-aryl-2,4-dialkyl-3H-1,2,4-triazole-3-thiones
EP0667334A3 (fr) Procédé de préparation d'acides 4-alkoxy-3,5,6-trifluorophthaliques et d'acides 3-alkoxy-2,4,5-trifluorobenzoiques.
AU6764796A (en) Process for the preparation of 3,3,5-trichloroglutarimide
HU9700366D0 (en) Novel derivatives of 3-bromo- and 3,3 dibromo-4-oxo-1-azetidines, process for the preparation thereof and their use
AU2476097A (en) Process for the preparation of 2,3-pyridinedicarboximides
AU5222298A (en) Process for the preparation of 1,8-naphthosultam